Sapacitabine
id:
sapacitabine-312-2385413
title:
Sapacitabine
text:
Sapacitabine is a chemotherapeutic drug developed by US biotechnology firm Cyclacel currently undergoing clinical trials against leukemia. Sapacitabine is an orally available nucleoside analog prodrug of 2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofuranosyl-cytosine (CNDAC) that acts through a dual mechanism. CNDAC lasts longer in the bloodstream by being metabolized from sapacitibine than it would do so by being directly administered. The compound interferes with DNA synthesis by causing single-stra
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Sapacitabine
date created:
date modified:
2023-11-07T19:07:26Z
main entity:
{"identifier":"Q7420893","url":"https://www.wikidata.org/entity/Q7420893"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1b/Sapacitabine.png","width":1778,"height":591}
fields total:
13
integrity:
15